ARS Pharmaceuticals advertising spend, FY2025
ARS Pharmaceuticals (SPRY) reported $99.8M of advertising expense for the fiscal year ended Dec 31, 2025. That is 118.4% of revenue of $84.3M. Up 698.4% from FY2024. Formerly Silverback Therapeutics.
Key facts
- Ad spend is 8.0x its FY2024 level ($12.5M), faster than revenue (0.9x).
- ARS Pharmaceuticals spends more on advertising than 25% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 26x the median of 4.5%.
Ad spend by fiscal year
Ad spend as % of revenue
Ad spend in context, FY2025
Advertising was 43.4% of selling, general and administrative expense. Advertising was 7.6x research and development spending. The company reported an operating loss of $179M.
| Advertising | $99.8M | AdvertisingExpense |
|---|---|---|
| Selling, general and administrative | $230M | ad spend = 43.4% |
| Research and development | $13.2M | ad spend = 7.6x R&D |
| Operating loss | -$179M | |
| Net loss | -$171M |
Same fiscal year and filing as the ad spend. Selling and marketing and SG&A usually include advertising.
History
Download CSV| Fiscal year | Period end | Ad spend | YoY | Revenue | Ad / revenue | Tag | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.8M | +698.4% | $84.3M | 118.4% | AdvertisingExpense | 10-K Mar 9, 2026 |
| FY2024 | Dec 31, 2024 | $12.5M | n/a | $89.1M | 14.0% | AdvertisingExpense | 10-K Mar 9, 2026 |
Ad spend, revenue and the ratio come from the linked filing. YoY compares each year with the fiscal year directly before it, under the same tag. A gap, a change of tag or a change of fiscal year end leaves it blank.
What the figure is
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Compared with similar spenders
The 6 companies closest to ARS Pharmaceuticals in latest-year ad spend.
| Rank | Company | Ad spend | Ad / revenue | YoY | Fiscal year |
|---|---|---|---|---|---|
| 338 | AutoZone | $101M | 0.5% | -7.6% | FY2026 |
| 339 | Sonic Automotive | $101M | 0.7% | +19.8% | FY2025 |
| 340 | A. O. Smith | $101M | 2.6% | +0.8% | FY2025 |
| 341 | Alaska Air Group | $101M | 0.7% | +4.1% | FY2025 |
| 342 | Wise Group | $101M | 4.0% | +60.8% | FY2026 |
| 343 | Ethos Technologies | $100M | 25.8% | +57.8% | FY2025 |
| 344 | ARS Pharmaceuticals | $99.8M | 118.4% | +698.4% | FY2025 |
Full ranking of 458 companies · Biggest increases #1 · Highest ad-to-revenue #1 · New $50M spenders #4 · More on ads than R&D #22 · Ads above operating profit #120
Questions
How much does ARS Pharmaceuticals spend on advertising?
ARS Pharmaceuticals spent $99.8M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Mar 9, 2026.
What percentage of revenue does ARS Pharmaceuticals spend on advertising?
118.4% of revenue in fiscal 2025 ($99.8M against $84.3M). The median across the 458 companies tracked is 4.5%.
Is ARS Pharmaceuticals spending more on advertising?
Yes. Ad spend rose 698.4% in fiscal 2025 from fiscal 2024.
How does ARS Pharmaceuticals rank by advertising spend?
#344 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.
Does ARS Pharmaceuticals spend more on advertising than on R&D?
Yes. In fiscal 2025 it spent $99.8M on advertising and $13.2M on research and development.
What does ARS Pharmaceuticals's advertising figure include?
Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).
Company and source
- Filing
- 10-K for FY2025, filed Mar 9, 2026
- Accession number
0001193125-26-097478- Company
- ARS Pharmaceuticals, Inc., CIK 1671858, SIC 2834 (Pharmaceutical Preparations)
- Former names
- Silverback Therapeutics
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Listed on
- Nasdaq
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- Data
- SEC EDGAR XBRL company facts, retrieved Nov 17, 2026. Methodology.
- Cite
- ARS Pharmaceuticals advertising spend, FY2024-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Mar 9, 2026), retrieved Nov 17, 2026. https://io.trudov.com/company/ars-pharmaceuticals/advertising-spend/
- Download
- CSV, all years · CSV, all 458 companies